Multi-gene signatures in breast cancer: actual clinical impact

被引：0
|
作者：
Simon P. Gampenrieder
Gabriel Rinnerthaler
Richard Greil
机构：
[1] Paracelsus Medical University Salzburg,IIIrd Medical department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Can
来源：
memo - Magazine of European Medical Oncology | 2014年 / 7卷 / 1期
关键词：
Breast cancer; Molecular pathology; Intrinsic subtypes; Gene expression; Prognostic; Predictive;
D O I：
10.1007/s12254-014-0130-3
中图分类号：
学科分类号：
摘要：
The molecular pathology has fundamentally modified our understanding of breast cancer. Today, breast cancer is understood as a heterogeneous disease consisting of at least five different subtypes. These subtypes show specific mRNA levels and somatic alterations and derive probably from different precursor cells. Multi-gene signatures enable us not only to differentiate these subtypes but also to define different risk groups for relapse after primary treatment. The clinical impact of these signatures is critically discussed in this review.
引用
收藏
页码：16 / 21
页数：5
相关论文
共 50 条
  • [41] Diagnostic yield of a custom-designed multi-gene cancer panel in Irish patients with breast cancer
    McVeigh, Una M.
    McVeigh, Terri P.
    Curran, Catherine
    Miller, Nicola
    Morris, Derek W.
    Kerin, Micheal J.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (03) : 849 - 864
  • [42] Diagnostic yield of a custom-designed multi-gene cancer panel in Irish patients with breast cancer
    Úna M. McVeigh
    Terri P. McVeigh
    Catherine Curran
    Nicola Miller
    Derek W. Morris
    Micheal J. Kerin
    [J]. Irish Journal of Medical Science (1971 -), 2020, 189 : 849 - 864
  • [43] PREVALENCE OF GENE MUTATIONS IN PATIENTS AT INCREASED RISK OF PANCREATIC CANCER: IMPACT OF MULTI-GENE PANEL TESTING
    Zhu, Huili
    Welinsky, Sara
    Soper, Emily
    Abul-Husn, Noura S.
    Lucas, Aimee L.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1086 - S1086
  • [44] PREVALENCE OF GENE MUTATIONS IN PATIENTS AT INCREASED RISK OF PANCREATIC CANCER: IMPACT OF MULTI-GENE PANEL TESTING
    Welinsky, Sara
    Soper, Emily
    Diaz, George
    Lucas, Aimee L.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S556 - S556
  • [45] Trends in clinical introduction of multi-gene panel testing (MGPT) in hereditary cancer diagnosis
    Yoshida, Reiko
    [J]. CANCER SCIENCE, 2022, 113 : 1382 - 1382
  • [46] Multi-gene Constructs
    Christou, P.
    Farre, G.
    Bai, C.
    Rivera, S. M.
    Sanahuja, G.
    Capell, T.
    Zhu, C.
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2011, 47 : S27 - S28
  • [47] Gene expression signatures in breast cancer
    Schmidt, M.
    [J]. ONKOLOGE, 2013, 19 (06): : 465 - +
  • [48] Psychological distress following multi-gene panel testing for hereditary breast and ovarian cancer risk
    Carlsson, Lindsay
    Bedard, Philippe L.
    Kim, Raymond H.
    Metcalfe, Kelly
    [J]. JOURNAL OF GENETIC COUNSELING, 2024,
  • [49] Genetic variation and the role of multi-gene testing for hereditary breast cancer: A single institution experience
    Lu, Kit Yu
    Smith, Meagan
    Verbiar, Julia
    Minor, Haleigh
    Lapse, Jennifer
    Blair, Latesha
    Torp, Lisa
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [50] Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer
    Zografos, Eleni
    Andrikopoulou, Angeliki
    Papatheodoridi, Alkistis Maria
    Kaparelou, Maria
    Bletsa, Garyfalia
    Liontos, Michalis
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    [J]. GENES, 2022, 13 (08)
12345